2) secondary IgA nephropathy
继发性IgA肾病
1.
Objective:To investigate the etiology, histopathological and immunofluorescence features in patients with secondary IgA nephropathy.
目的:分析继发性IgA肾病(IgAN)的病因、肾活检组织学及免疫病理特征。
3) experimental IgA nephropathy
实验性IgA肾病
1.
Effects of leflunomide on renal pathology and expression of MCP-1 in renal tissue in rat experimental IgA nephropathy model;
Leflunomide对实验性IgA肾病大鼠肾脏病理及MCP-1表达的影响
2.
Objective:To explore traditional Chinese medicine Rosa Laevigata Michx extract liquid on the treatment of experimental IgA nephropathy,understanding its mechanism.
目的:探索传统中药金樱子(Rosa Laeviga Michx,RLM)水醇提取液对实验性IgA肾病的治疗作用,了解其作用机制。
4) primary IgA nephropathy
原发性IgA肾病
1.
Objective: to study the clinico-pathological features in xinjiang uigur and Chinese patients with primary IgA nephropathy.
目的：初步探讨新疆维吾尔族和汉族原发性IgA肾病临床及病理特点；方法：对1999年6月至2005年12月在新疆维吾尔自治区人民医院肾内科住院并经肾活检确诊的维吾尔族和汉族原发性IgA肾病患者进行流行病学，临床表现及病理特征的回顾性分析；结果：维吾尔族和汉族原发性IgA肾病患者分别为46例和71例，分别占同期同民族原发性肾小球疾病的17。
2.
Results Primary IgA nephropathy with low complement C3 hyperlipidemia and no significant correlation between the clinical manifestations,X2 test there was no significant difference.
目的探讨原发性IgA肾病与低补体血症的关系。
6) chronic progressive renal disease
慢性进展性肾病
1.
Current researches of angiotensin receptor blockers in treatment of patients with chronic progressive renal disease;
血管紧张素受体阻滞剂治疗慢性进展性肾病的研究进展
补充资料：继发性胆汁性肝硬化
继发性胆汁性肝硬化
secondary biliary cirrhosis
各种原因的肝外胆管阻塞或上行性感染引起的肝硬化。肝增大、色深绿、质中等，表面有细颗粒结节。临床主要有梗阻性黄疸及原发疾病的症状，肝功能损害较轻；晚期可出现门静脉高压。如能去除病因，肝硬化可部分恢复。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条